BioStem Technologies Secures Funding Through Private Placement
PUBLIC · BSEMSep 29, 2026
Amount Raised
$3 Million
Round Type
Post-IPO Equity
Pompano BeachBiotechnology
Description
On September 29, 2026, BioStem Technologies, Inc. entered into a securities purchase agreement for a private placement, selling an aggregate of 735,296 shares of common stock. The shares were issued at a price of $4.08 per share along with Series A and Series B warrants. This funding is expected to enhance the company's financial position and support its growth initiatives
Company Information
Company
BIOSTEM TECHNOLOGIES
Location
2836 CENTER PORT CIRCLE
Pompano Beach, Florida, United States
About
BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. The Company is focused on manufacturing products that change lives, leveraging its proprietary BioRetain processing method. BioRetain has been developed by applying the latest research in regenerative medicine, focused on maintaining growth factors and preserving tissue structure. BioStem Technologies' quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks ("AATB"). These systems and procedures are established per current Good Tissue Practices ("cGTP") and current Good Manufacturing Processes ("cGMP"). Our portfolio of quality brands includes VENDAJE, VENDAJE AC, and VENDAJE OPTIC. Each BioStem Technologies placental allograft is processed at the Company's FDA registered and AATB accredited site in Pompano Beach, Florida.
Fundz sees it the moment BIOSTEM TECHNOLOGIES raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Pompano BeachBiotechnology